Recent research has focused on the detection in peripheral blood of rare circulating tumor cells (CTCs), which serve as ...

The lab of Filippo Veglia ... cancers reprogram immune system cells from fighting cancer to enabling further tumor growth. The team's findings were published in the paper "Functional reprogramming ...

A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...

Consequently, effective treatments for brain tumors are limited. However, physicians and scientists are working together to better characterize tumor heterogeneity and identify markers to best target ...

We are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers ...

Mexico's premier center for regenerative medicine, anti-aging therapies, and advanced diagnostics, is proud to announce our collaboration with OncoInv - a global leader in multi-cancer early detection ...

Backed by well-established scientific literature, these LMI-lab tumor markers provide enhanced sensitivity for several high-risk cancers. Patients benefit from improved detection of prostate ...

Mexico's premier center for regenerative medicine, anti-aging therapies, and advanced diagnostics, is proud to announce our collaboration with OncoInv - a global leader in multi-cancer early detection ...